Reaction Details Report a problem with these data
Target
Flavin reductase (NADPH)
Ligand
BDBM50058291
Substrate
n/a
Meas. Tech.
ChEMBL_2153628 (CHEMBL5038175)
Kd
1349±n/a nM
Citation
 Kim, M; Ha, JH; Choi, J; Kim, BR; Gapsys, V; Lee, KO; Jee, JG; Chakrabarti, KS; de Groot, BL; Griesinger, C; Ryu, KS; Lee, D Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IX? Reductase B as a Novel Thrombocytopenia Therapeutic Target. J Med Chem 65:2548-2557 (2022) [PubMed]  Article 
Target
Name:
Flavin reductase (NADPH)
Synonyms:
1.3.1.24 | 1.5.1.30 | BLVRB | BLVRB_HUMAN | BVR-B | Biliverdin reductase B | Biliverdin-IX beta-reductase | FLR
Type:
PROTEIN
Mol. Mass.:
22123.63
Organism:
Homo sapiens
Description:
ChEMBL_100283
Residue:
206
Sequence:
MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAADVDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTKVPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHDLGHFMLRCLTTDEYDGHSTYPSHQYQ
  
Inhibitor
Name:
BDBM50058291
Synonyms:
CHEBI:87193 | CHEMBL1205178
Type:
Small organic molecule
Emp. Form.:
C20H4Br4Cl4O5
Mol. Mass.:
785.671
SMILES:
OC(=O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2cc(Br)c(O)c(Br)c2oc2c(Br)c(=O)c(Br)cc12 |(17.43,-2.64,;16.66,-3.99,;17.43,-5.3,;15.12,-3.99,;15.12,-2.45,;16.43,-1.68,;13.77,-1.68,;13.77,-.14,;12.46,-2.45,;11.11,-1.68,;12.46,-3.99,;11.11,-4.76,;13.77,-4.76,;13.8,-6.3,;12.46,-7.07,;11.11,-6.3,;9.79,-7.1,;8.45,-6.33,;9.79,-8.64,;8,-9.7,;11.11,-9.41,;11.14,-10.95,;12.46,-8.64,;13.8,-9.41,;15.12,-8.61,;16.46,-9.38,;16.46,-10.92,;17.81,-8.61,;19.13,-9.38,;17.81,-7.07,;19.13,-6.3,;16.46,-6.3,;15.12,-7.07,)|
Structure:
Search PDB for entries with ligand similarity: